Structure Therapeutics Inc.: Morgan Stanley cuts target price to $117 from $126
GPCR•Morgan Stanley cut its target price for Structure Therapeutics Inc. to $117 from $126.
Related News
Fed's Warsh to take stock of AI revolution as US public grows wary
SPY•
Bath & Body Works: Morgan Stanley raises target price to $22 from $20
BBWI•
Macy's, Inc.: Morgan Stanley raises target price to $31 from $30
M•
Ryde Group appoints Chen Chong, Vincent Suen as independent directors
RYDE•
X-energy: Morgan Stanley cuts target price to $30 from $34
XE•